Dylan Larkin

Dylan Larkin

Ask VT AI
View News Summary
  • Campbell Soup's Q3 sales rise, but snacks division struggles amid economic uncertainty and higher costs.
  • Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
  • Padres' Gavin Sheets exits after face-first wall collision, raising concerns about the team's limited healthy options in left field.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Campbell Soup's Q3 sales rise, but snacks division struggles amid economic uncertainty and higher costs.
  • Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
  • Padres' Gavin Sheets exits after face-first wall collision, raising concerns about the team's limited healthy options in left field.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Dylan Larkin